AAKAAR Share Price | Aakaar Medical Technologies Ltd Stock Analysis & Recommendation

Q: Why is Aakaar Medical Technologies Ltd falling/rising?

As of 06-Feb, Aakaar Medical Technologies Ltd is experiencing a decline in its stock price. The current price is Rs. 51.00, which is at the new 52-week and all-time low, indicating a significant drop in value. Over the past week, the stock has decreased by 4.40%, and it has seen a substantial decline of 26.99% over the past month. Year-to-date, the stock is down 30.85%, contrasting sharply with the Sensex, which has only fallen by 1.67% during the same period.Despite today's performance showing that the stock has outperformed its sector by 0.8%, it is still trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a bearish trend in the stock's performance. However, there has been a notable increase in investor participation, with delivery volume rising by 800% against the 5-day average, indicating some interest from investors despite the overall downward trend.In summary, the combination of hitting a new low, significant declines over multiple periods, and trading below moving averages contributes to the stock's falling price, despite some positive indicators in investor participation.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.4 k (-9.09%) Volume

Shareholding (Sep 2025)

FII

0.50%

Held by 1 FIIs

DII

10.73%

Held by 0 DIIs

Promoter

67.01%

Is Aakaar Medical overvalued or undervalued?

18-Nov-2025

As of November 17, 2025, Aakaar Medical is considered overvalued with a PE ratio of 18.23 and an EV to EBITDA ratio of 12.87, despite being lower than some peers like Sun Pharma and Divi's Lab, while its recent stock performance has underperformed the Sensex with returns of -3.24% over the past week and -11.37% over the past month.

View full answer

Why is Aakaar Medical Technologies Ltd falling/rising?

07-Feb-2026

As of 06-Feb, Aakaar Medical Technologies Ltd's stock price has dropped to Rs. 51.00, marking a new 52-week low with a 30.85% decline year-to-date. Despite increased investor participation, the stock remains below its moving averages, indicating a bearish trend.

View full answer

Which are the latest news on Aakaar Medical?

07-Feb-2026

Is Aakaar Medical overvalued or undervalued?
Is Aakaar Medical overvalued or undervalued?

Compare Aakaar Medical with Similar Stocks

Invicta Diagnos.Aspira Pathlab Choksi Laborator

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 72 Cr (Micro Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.33

Return on Equity

12.79%

Price to Book

1.53

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-39.18%

6 Months

-40.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Aakaar Medical for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Is Aakaar Medical overvalued or undervalued?

As of 17 November 2025, Aakaar Medical's valuation grade has moved from very expensive to expensive. The company is currently considered overvalued based on its financial metrics. The PE ratio stands at 18.23, while the EV to EBITDA ratio is 12.87, and the ROCE is 15.34%. In comparison to its peers, Aakaar Medical's PE ratio is significantly lower than that of Sun Pharma, which has a PE of 36.69, and Divi's Lab, which is at 69.78. However, it is higher than some peers like Dr. Reddy's Labs, which has a PE of 17.98. The recent performance shows that Aakaar Medical has underperformed the Sensex over the past week and month, with stock returns of -3.24% and -11.37%, respectively, reinforcing the notion of its overvaluation....

Read full news article

Is Aakaar Medical overvalued or undervalued?

As of 13 November 2025, Aakaar Medical's valuation grade has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently considered overvalued. Key ratios include a PE Ratio of 18.10, an EV to EBIT of 12.95, and a Price to Book Value of 2.32. In comparison to its peers, Aakaar Medical's PE Ratio is considerably lower than that of Sun Pharma Industries at 36.15 and Divi's Lab at 70.4, both categorized as very expensive. Additionally, while Aakaar Medical's EV to EBITDA stands at 12.79, it is still less favorable compared to Torrent Pharma's 32.99. The recent stock performance shows a decline of 8.17% over the past week, contrasting with a 1.45% gain in the Sensex, further supporting the notion of overvaluation....

Read full news article

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

33.60%

EBIT Growth (5y)

97.74%

EBIT to Interest (avg)

4.95

Debt to EBITDA (avg)

1.75

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.96

Tax Ratio

25.65%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

11.23%

ROCE (avg)

15.34%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.53

EV to EBIT

9.13

EV to EBITDA

9.01

EV to Capital Employed

1.40

EV to Sales

1.43

PEG Ratio

Dividend Yield

ROCE (Latest)

15.34%

ROE (Latest)

12.79%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.5%)

Promoter with highest holding

Dilip Ramesh Meswani (48.16%)

Highest Public shareholder

India Equity Fund 1 (4.96%)

Individual Investors Holdings

16.47%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aakaar Medical"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.32",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.23",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "1.04",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.78",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.91%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Aakaar Medical"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "61.58",
          "val2": "46.11",
          "chgp": "33.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.76",
          "val2": "5.00",
          "chgp": "95.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.71",
          "val2": "1.14",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.03",
          "val2": "2.87",
          "chgp": "110.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.85%",
          "val2": "10.84%",
          "chgp": "5.01%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Change(%)

Net Sales

25.32

Operating Profit (PBDIT) excl Other Income

-0.23

Interest

1.04

Exceptional Items

0.00

Standalone Net Profit

-0.78

Operating Profit Margin (Excl OI)

-0.91%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

61.58

46.11

33.55%

Operating Profit (PBDIT) excl Other Income

9.76

5.00

95.20%

Interest

1.71

1.14

50.00%

Exceptional Items

0.00

Standalone Net Profit

6.03

2.87

110.10%

Operating Profit Margin (Excl OI)

15.85%

10.84%

5.01%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Aakaar Medical Technologies Ltd

Aakaar Medical Technologies Ltd

Micro Cap

Healthcare Services

No Details Available.

Company Coordinates

No Company Details Available

Aakaar Medical

1Day

52 Week

CASH

FII

DII

Promoter

Is Aakaar Medical overvalued or undervalued?

Watch in Real-Time

Why is Aakaar Medical Technologies Ltd falling/rising?

Which are the latest news on Aakaar Medical?

Compare Aakaar Medical with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

Is Aakaar Medical overvalued or undervalued?

Is Aakaar Medical overvalued or undervalued?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Half Yearly Results Snapshot (Standalone) - Sep'25

Annual Results Snapshot (Standalone) - Mar'25

About Aakaar Medical Technologies Ltd

Company Coordinates